2′-OMe-Bz-A-CEP
Our comprehensive 2′ modified RNA phosphoramidites portfolio is uniquely designed for oligonucleotide therapeutic development and manufacturing. Seamlessly scale up your synthesis of siRNA and ASO for RNA therapeutics from early-stage development to commercialization with the comprehensive supply of Thermo Scientifics phosphorarmidites.
Thermo Scientific 2′ modified RNA phosphoramidites
Modifications at the 2′ position of the ribose ring are commonly used to help increase oligonucleotide stability and improve resistance to nuclease activity in vivo. Our 2'-modified RNA phosphoramidites are manufactured to precise standards to help ensure quality, consistency, and reliability for efficient synthesis of nucleic acid-based therapeutics. Multiple quality grades of TheraPure, standard, or fast deprotect phosphoramidites are available to choose from.
2'-OMe phosphoramidites
TheraPure and standard grades 2′-OMe phosphoramidites are available for oligo synthesis of diagnostics or therapeutics manufacturing. For faster deprotection times, consider reviewing the PAC chemistries in combination with 2'-OMe U (no base protection) and Ac-rC.
Available 2′-OMe modified RNA phosphoramidites by synthesizer compatibility
Modification | 2'-OMe phosphoramidites | |||||
Common applications | siRNA (small interfering RNA) | Diagnostics | ||||
Quality grades |
| Fast deprotect | ||||
Featuring quality attribute |
| Allow the removal of base-protecting groups under mild or accelerated conditions | ||||
Bz-A | U | G | C | PAC-A | iPrPAC-G | |
Applied Biosystems/AKTA Synthesizer | 27-2042-04 | 27-2044-04 | 27-2046-04 | 27-2043-04 | 27-1822-02 | 27-1826-02 |
Expedite Synthesizer | 27-2042-10 | 27-2044-10 | 27-2046-10 | 27-2043-10 | 27-1822-10 | 27-1826-10 |
MerMade Synthesizer | Custom orders are available. | 27-1822-11 | 27-1826-11 |
Manufacturing for therapeutics with high purity requirement
Quality attributes of 2′-OMe phosphoramidites are presented in the table below.
Click images to enlarge
2′-OMe-Bz-A-CEP | 2′-OMe-U-CEP | 2′-OMe-iBu-G-CEP | 2′-OMe-Ac-C-CEP | |
---|---|---|---|---|
TheraPure grade Cat. No. | 27-2042 | 27-2044 | 27-2046 | 27-2043 |
Standard grade Cat. No. | 27-1842 | 27-1825 | 27-1846 | 27-1823 |
Formula | C48H54N7O8P | C40H56N7O9P | C45H56N7O9P | C42H52N5O9P |
Molecular weight | 887.97 g/mol | 760.8 g/mol | 869.9 g/mol | 801.86 g/mol |
CAS # | 110782-31-5 | 110764-79-9 | 150780-67-9 | 199593-09-4 |
Appearance | Color intensity must not exceed Pantone #P1-4U or #P4-2U | |||
HPLC purity (TheraPure phosphoramidites) | ≥ 98.0% | (>99%) * | |||
M-11 Impurity | ≤ 0.01% | |||
31P NMR purity (TheraPure phosphoramidites) | ≥ 98.0% | (>99%) * | |||
Shipping / Storage condition | Ambient / –20 °C | |||
Water content | ≤ 0.2% (KF Method) | |||
Material Origin | Non-animal source (no TSE/BSE risk) |
Compatible products by synthesizer model
Available 2′-OMe phosphoramidites in TheraPure or standard grades and are compatible with the following oligonucleotide synthesizers:
- Applied Biosystems / AKTA Synthesizer
- Expedite Synthesizer
- MerMade Synthesizer—Custom order only; contact us for a quote
Compatible products with the Applied Biosystems and AKTA synthesizer
Compatible products are in amber bottles with serum vial neck style as ready-to-ship catalog SKU for your siRNA and ASO synthesis.
Expedite synthesizer
Available catalog SKUs are supplied in 30 mL amber bottle with a 20-400 finish neck style. Compatible with the Expedite synthesizer for antisense, siRNA, aptamer, or gRNA-based research.
Manufacturing for diagnostic applications
Utilize PAC-A and iPrPAC-G with Ac-C and U to minimize deprotection times. Acetylated amidites (such as Ac-G, SY5400) are excellent for shortening deprotection times for longmers.
2′-OMe-PAC-A-CEP | 2′-OMe-iPrPAC-G-CEP | TheraPure 2'-OMe-Ac-G-CEP | ||
---|---|---|---|---|
Cat. No. | 27-1822 | 27-1826 | SY5400 | |
Formula | C49H56N7O9P | C52H62N7O10P | C43H52N7O9P | |
Molecular weight | 918.0 g/mol | 976.1 g/mol | 841.9 g/mol | |
CAS # | 128219-82-9 | NA | 909033-40-5 | |
HPLC purity | ≥ 98.0% | ≥ 98.0% | ≥ 99% | |
31P NMR purity | ≥ 98.0% | ≥ 98.0% | ≥ 99% | |
Hazardous | No | |||
Shipping / Storage condition | Ambient / –20 °C | |||
Material Origin | Non-animal source (no TSE/BSE risk) |
C52H62N7O10P |
Compatibility by synthesizer model
2′-OMe modified RNA phosphoramidites are compatible with the following oligonucleotide synthesizers:
- Applied Biosystems and AKTA Synthesizer
- Expedite Synthesizer
- MerMade Synthesizer
Applied Biosystems and AKTA synthesizer
Compatible catalog products are ready-to-ship in amber bottles with serum vial neck style.
Expedite synthesizer
Available catalog SKUs are supplied in 30 mL amber bottle with a 20-400 finish neck style.
MerMade systems synthesizer
Compatible products are available to ship in a 30 mL amber bottle with a 28-400 finish neck style.
2'-Fluoro Phosphoramidites
Synthesizing RNA oligonucleotides using 2′-Fluoro Bz A, iBu G, Ac C, and U phosphoramidites increases the thermal stability of RNA duplexes and increases the nuclease resistance of single-stranded RNA. These phosphoramidites can be incorporated into custom siRNA oligonucleotides for use in gene-targeting and suppression studies.
Available 2'-Flouro modified phosphoramidites by compatible synthesizers
Modifications | 2'-Fluoro phosphoramidites | ||||
Common applications | siRNA (small interfering RNA) | ||||
Quality grades | TheraPure | Standard | |||
Featuring quality attribute | Maximal QC and analytical testing supported by documentation | Traditional base protection method. Highly reliable for routine oligo synthesis | |||
Ac-C | U | Ac-G | Bz-A | iBu-G | |
Applied Biosystems/AKTA Synthesizer | 27-1604-02 | 27-1602-02 | Custom orders are available.
| 27-1601.02 | 27-1607-02 |
Expedite Synthesizer | 27-1604-09 | 27-1602-09 | 27-1601-09 | 27-1607-09 | |
MerMade Synthesizer | 27-1604-12 |
| 27-1601.12 | 27-1607-12 |
Technical specifications for 2'-Flouro modification
Click images to enlarge
2′-F-Ac-C-CEP | 2′-F-U-CEP | 2'-F-Ac-G-CEP | 2′-F-Bz-A-CEP | 2′-F-iBu-G-CEP | |
---|---|---|---|---|---|
Quality grade | Therapure | Standard | |||
Cat. No. | 27-1604 | 27-1602 | SY5410* | 27-1601 | 27-1607 |
Formula | C41H49N5FO8P | C39H46FN4O8P | C42H49FN7O8P | C47H51FN7O7P | C44H53FN7O8P |
Molecular weight | 798.8 g/mol | 748.8 g/mol | 829.87 g/mol | 875.92 g/mol | 857.4 g/mol |
CAS # | 159414-99-0 | 146954-75-8 | N/A | N/A | 144089-97-4 |
Residual Solvent | ≤ 3.0% total % by weight solvent | N/A | |||
Appearance | White to light yellow powder | ||||
HPLC purity* | >98% | ||||
31P NMR purity* | >98% | ||||
Solution Clarity | Free from undissolved particulate at 0.2 M solution in ACN | ||||
Shipping / Storage condition | Ambient / –20 C | ||||
Water content | ≤ 0.3% | ||||
Material Origin | Non-animal source (no TSE/BSE risk) |
Compatibility by synthesizer model
2′-Fluoro modified RNA phosphoramidites are compatible with the following oligonucleotide synthesizers:
- Applied Biosystems / AKTA Synthesizer
- Expedite Synthesizer
- MerMade Synthesizer
Applied Biosystems and AKTA synthesizer
Order compatible products in amber bottles with serum vial neck style. Available in TheraPure and standard quality grades.
Expedite synthesizer
Available catalog SKUs are supplied in 30 mL amber bottle with a 20-400 finish neck style. Choose from quality grades of TheraPure or standard.
MerMade systems synthesizer
Catalog SKUs available that are compatible with the MerMade synthesizer in a 30 mL amber bottle with a 28-400 finish neck style.
2'-MOE phosphoramidites
RNA oligonucleotides synthesized using 2′-MOE modifications phosphoramidites have shown to be more nuclease resistant, with lower toxicity, and slightly increased hybridization affinities, making them well suited for therapeutic in vivo applications, such as antisense (ASO), siRNA, and aptamers.
- Tightly controlled, critical impurities (e.g., M-11)
- Suitable for use with DNA and/or RNA phosphoramidites
- Reliable, high quality oligonucleotide synthesis
Available 2'-MOE modified phosphoramidites by compatible synthesizers
Modifications | 2'-MOE phosphoramidites | |||
Common applications | ASO (antisense oligonucleotides) | |||
Quality grades | TheraPure | |||
Featuring quality attribute | Maximal QC testing to help ensure impurities and residual solvents are within the stringent requirement for oligo therapeutics | |||
A | 5mC | G | T | |
Applied Biosystems/AKTA Synthesizer | 27-1019-02 | 27-1020-02 | 27-1022-02 | 27-1021-02 |
Expedite Synthesizer | Custom orders are available. | |||
MerMade Synthesizer | 27-1019-11 | 27-1020-11 | 27-1022-11 | 27-1021-11 |
Technical specifications of 2'-MOE modification
Click images to enlarge
2′-MOE-A CEP | 2′-MOE-5mC CEP | 2′-MOE-G CEP | 2′-MOE-T CEP | |
---|---|---|---|---|
Quality grade | TheraPure | TheraPure | TheraPure | TheraPure |
Cat. No. | 27-1019 | 27-1020 | 27-1022 | 27-1021 |
Formula | C50H58N7O9P | C50H60N5O10P | C47H60N7O10P | C43H55N4O10P |
Molecular weight | 932.03 g/mol | 922.0 g/mol | 914.01 g/mol | 819.0 g/mol |
CAS # | 251647-53-7 | 163759-94-2 | 251647-55-9 | 163878-63-5 |
Solution clarity | Free from undissolved particulate at 0.2 M solution in ACN | |||
HPLC purity* | ≥99% | |||
31P NMR purity* | ≥99% | |||
Shipping / Storage condition | Ambient / –20°C | |||
Water content | ≤0.3% (by KF Method) | |||
Total residual solvents | ≤4.0% | |||
Material origin | Non-animal source (no TSE/BSE risk) |
Compatibility by synthesizer model
TheraPure RNA phosphoramidites with 2′-MOE modifications are compatible with the following oligonucleotide synthesizers:
- Applied Biosystems / AKTA Synthesizer
- Expedite Synthesizer: Custom order only; contact us for a quote
- MerMade Synthesizer
Applied Biosystems and AKTA synthesizer
Compatible catalog products of 1 g or 5 g are ready-to-ship in amber bottles with serum vial neck style.
MerMade systems synthesizer
Catalog SKUs compatible to MerMade synthesizer are ready-to-ship in 30 mL amber bottle with a 28-400 finish neck style. Sizing options of 1 g or 2 g are available to choose from.
Looking for additional size options, customization, or packaging solutions?
Technical Spotlights
Custom Services and Quotation
Speak with a technical specialist about support available for the oligonucleotide manufacturing process development of your unique projects.
Phosphoramidite Learning Resource
Access webinars, videos, articles, and more to optimize your success in oligonucleotide synthesis for diagnostic and therapeutic manufacturing process development.
mRNA Production Learning Library
Browse the educational assets related to raw materials selection, process development using in vitro transcription, scale-up synthesis, and the latest trends in mRNA production.
For Research Use Only. Not for use in diagnostic procedures.